JPS56112907A
(en)
*
|
1980-02-12 |
1981-09-05 |
Japan Atom Energy Res Inst |
Production of polymer composition including bioactive substance
|
WO1982000091A1
(en)
*
|
1980-07-01 |
1982-01-21 |
V Ketharanathan |
Vascular prostheses
|
US4378224A
(en)
*
|
1980-09-19 |
1983-03-29 |
Nimni Marcel E |
Coating for bioprosthetic device and method of making same
|
US4388735A
(en)
*
|
1980-11-03 |
1983-06-21 |
Shiley Inc. |
Low profile prosthetic xenograft heart valve
|
US4384374A
(en)
*
|
1981-03-27 |
1983-05-24 |
Muldashev Ernst R |
Homotransplant for layer-by-layer keratoplasty
|
US4372743A
(en)
*
|
1981-06-22 |
1983-02-08 |
American Hospital Supply Corp. |
Low-pressure fixation of valvular tissue intended for implantation
|
FR2510598A1
(fr)
*
|
1981-07-30 |
1983-02-04 |
Inst Francais Du Petrole |
Utilisation d'additifs azotes comme agents d'abaissement du point de trouble des distillats moyens d'hydrocarbures et compositions de distillats moyens d'hydrocarbures renfermant lesdits additifs
|
US4481009A
(en)
*
|
1982-05-13 |
1984-11-06 |
American Hospital Supply Corporation |
Polymer incorporation into implantable biological tissue to inhibit calcification
|
US4801299A
(en)
*
|
1983-06-10 |
1989-01-31 |
University Patents, Inc. |
Body implants of extracellular matrix and means and methods of making and using such implants
|
ZA843751B
(en)
*
|
1983-06-10 |
1984-12-24 |
University Patents Inc |
Body implants of extracellular matrix and means and methods of making and using such implants
|
EP0160025B1
(en)
*
|
1983-10-20 |
1989-12-13 |
KETHARANATHAN, Vettivetpillai |
Biomaterial
|
US4553974A
(en)
*
|
1984-08-14 |
1985-11-19 |
Mayo Foundation |
Treatment of collagenous tissue with glutaraldehyde and aminodiphosphonate calcification inhibitor
|
NO166836C
(no)
*
|
1985-03-14 |
1991-09-11 |
Univ California |
Fremgangsmaate for behandling av et organtransplantat.
|
US4729139A
(en)
*
|
1985-11-05 |
1988-03-08 |
Baxter Travenol |
Selective incorporation of a polymer into implantable biological tissue to inhibit calcification
|
US4770665A
(en)
*
|
1985-11-05 |
1988-09-13 |
American Hospital Supply Corporation |
Elastomeric polymer incorporation into implantable biological tissue to inhibit calcification
|
WO1987002880A1
(en)
*
|
1985-11-13 |
1987-05-21 |
Domedica Pty. Limited |
Treatment of collagenous tissue
|
US4786287A
(en)
*
|
1986-10-10 |
1988-11-22 |
Baxter Travenol Laboratories |
Process for decreasing residual aldehyde levels in implantable bioprosthetic tissue
|
US4813964A
(en)
*
|
1986-10-14 |
1989-03-21 |
Hancock Jaffe Laboratories |
Crosslinked anisotropic xenogeneic diaphragm tissue in flexor tendon pulley reconstruction
|
US5139527A
(en)
*
|
1987-12-17 |
1992-08-18 |
Immuno Aktiengesellschaft |
Biologic absorbable implant material for filling and closing soft tissue cavities and method of its preparation
|
JP2772087B2
(ja)
*
|
1988-02-03 |
1998-07-02 |
バイオメディカル・デザイン・インコーポレーテッド |
補綴材のカルシウム沈着の防止
|
AT398276B
(de)
*
|
1989-05-31 |
1994-11-25 |
Sorin Biomedica Spa |
Verfahren zur präparierung von biologischem implantationsmaterial
|
US5283058A
(en)
|
1990-08-30 |
1994-02-01 |
The General Hospital Corporation |
Methods for inhibiting rejection of transplanted tissue
|
US5374539A
(en)
*
|
1991-06-17 |
1994-12-20 |
Nimni; Marcel E. |
Process for purifying collagen and generating bioprosthesis
|
ZA929119B
(en)
*
|
1991-11-26 |
1994-09-21 |
Res Dev Foundation |
Fetal membrane tubes and nerve and vessel grafts
|
US5342387A
(en)
*
|
1992-06-18 |
1994-08-30 |
American Biomed, Inc. |
Artificial support for a blood vessel
|
US5437287A
(en)
*
|
1992-08-17 |
1995-08-01 |
Carbomedics, Inc. |
Sterilization of tissue implants using iodine
|
AU695120B2
(en)
*
|
1993-06-07 |
1998-08-06 |
Baylor College Of Medicine |
Use of an MHC class I suppressor drug for the treatment of autoimmune diseases and transplantation rejection
|
US6203755B1
(en)
|
1994-03-04 |
2001-03-20 |
St. Jude Medical, Inc. |
Electron beam sterilization of biological tissues
|
US5443824A
(en)
*
|
1994-03-14 |
1995-08-22 |
Piacquadio; Daniel J. |
Topical thalidomide compositions for surface or mucosal wounds, ulcerations, and lesions
|
US5595571A
(en)
*
|
1994-04-18 |
1997-01-21 |
Hancock Jaffe Laboratories |
Biological material pre-fixation treatment
|
USRE40570E1
(en)
|
1994-07-29 |
2008-11-11 |
Edwards Lifesciences Corporation |
Apparatuses and methods for treating biological tissue to mitigate calcification
|
US5931969A
(en)
*
|
1994-07-29 |
1999-08-03 |
Baxter International Inc. |
Methods and apparatuses for treating biological tissue to mitigate calcification
|
WO1996004028A1
(en)
*
|
1994-07-29 |
1996-02-15 |
Baxter International Inc. |
Methods for treating implantable biological tissues to mitigate the calcification thereof and bioprosthetic articles treated by such methods
|
US5782931A
(en)
*
|
1996-07-30 |
1998-07-21 |
Baxter International Inc. |
Methods for mitigating calcification and improving durability in glutaraldehyde-fixed bioprostheses and articles manufactured by such methods
|
US6152142A
(en)
*
|
1997-02-28 |
2000-11-28 |
Tseng; Scheffer C. G. |
Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
|
US5891196A
(en)
*
|
1997-04-16 |
1999-04-06 |
Baxter International Inc. |
Method for actively binding heparin to crosslinked biological tissues
|
US5958669A
(en)
*
|
1997-05-02 |
1999-09-28 |
St. Jude Medical, Inc. |
Apparatus and method for crosslinking to fix tissue or crosslink molecules to tissue
|
US6008292A
(en)
*
|
1997-12-02 |
1999-12-28 |
Baxter International Inc. |
Method for inhibiting calcification of aldehyde-fixed bioprosthetic materials
|
US6214054B1
(en)
|
1998-09-21 |
2001-04-10 |
Edwards Lifesciences Corporation |
Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
|
US6214055B1
(en)
*
|
1998-10-30 |
2001-04-10 |
Mures Cardiovascular Research, Inc. |
Method and kit for rapid preparation of autologous tissue medical devices
|
US6524339B1
(en)
|
1999-01-27 |
2003-02-25 |
David H. Adams |
Cryopreserved homografts and other stentless bioprosthetic heart valves having natural tissue sewing rings
|
US6471723B1
(en)
*
|
2000-01-10 |
2002-10-29 |
St. Jude Medical, Inc. |
Biocompatible prosthetic tissue
|
AU5380201A
(en)
*
|
2000-04-27 |
2001-11-07 |
Ray Jui Fang Tsai |
Method for expansion of epithelial stem cells
|
JP2004512262A
(ja)
|
2000-06-20 |
2004-04-22 |
アイデック ファーマスーティカルズ コーポレイション |
非放射性抗cd20抗体/放射標識抗cd22抗体の組合せ
|
RU2003114422A
(ru)
*
|
2000-11-28 |
2004-11-20 |
Джинентех, Инк. (US) |
Соединения-антагонисты lfa-1
|
US20020159996A1
(en)
|
2001-01-31 |
2002-10-31 |
Kandasamy Hariharan |
Use of CD23 antagonists for the treatment of neoplastic disorders
|
EP2067486A1
(en)
|
2001-01-31 |
2009-06-10 |
Biogen Idec Inc. |
Use of CD23 antagonists for the treatment of neoplastic disorders
|
US6878168B2
(en)
|
2002-01-03 |
2005-04-12 |
Edwards Lifesciences Corporation |
Treatment of bioprosthetic tissues to mitigate post implantation calcification
|
US8308797B2
(en)
|
2002-01-04 |
2012-11-13 |
Colibri Heart Valve, LLC |
Percutaneously implantable replacement heart valve device and method of making same
|
CN1705439A
(zh)
*
|
2002-04-12 |
2005-12-07 |
细胞基因公司 |
干细胞和祖细胞分化的调节、鉴定及其应用
|
US7498171B2
(en)
*
|
2002-04-12 |
2009-03-03 |
Anthrogenesis Corporation |
Modulation of stem and progenitor cell differentiation, assays, and uses thereof
|
KR20070055625A
(ko)
|
2002-12-16 |
2007-05-30 |
제넨테크, 인크. |
이뮤노글로불린 변이체 및 이들의 용도
|
RU2358762C9
(ru)
|
2003-04-09 |
2016-10-10 |
Джинентех, Инк. |
Лечение аутоиммунных заболеваний у пациента с неадекватным ответом на ингибитор tnf-альфа
|
CA2562243A1
(en)
*
|
2004-04-16 |
2005-12-08 |
Genetech, Inc. |
Treatment of polychondritis and mononeuritis multiplex with anti-cd20 antibodies
|
JP2007532681A
(ja)
*
|
2004-04-16 |
2007-11-15 |
ジェネンテック・インコーポレーテッド |
B細胞の枯渇を増大させる方法
|
KR20070029733A
(ko)
|
2004-06-04 |
2007-03-14 |
제넨테크, 인크. |
다발성 경화증의 치료 방법
|
JP2008524241A
(ja)
*
|
2004-12-17 |
2008-07-10 |
ジェネンテック・インコーポレーテッド |
従来の治療の効果がなかった患者の自己免疫性疾患の血管新生阻害治療
|
US20060263357A1
(en)
|
2005-05-05 |
2006-11-23 |
Tedder Thomas F |
Anti-CD19 antibody therapy for autoimmune disease
|
JP5651285B2
(ja)
|
2005-02-15 |
2015-01-07 |
デューク ユニバーシティ |
抗cd19抗体および腫瘍学における使用
|
TW200714289A
(en)
*
|
2005-02-28 |
2007-04-16 |
Genentech Inc |
Treatment of bone disorders
|
BRPI0607985A2
(pt)
|
2005-03-10 |
2009-10-27 |
Genentech Inc |
modulador da dscr1, métodos de tratamento, método de melhoria de efeitos colaterais e método de inibição do crescimento de tumores
|
US7579381B2
(en)
*
|
2005-03-25 |
2009-08-25 |
Edwards Lifesciences Corporation |
Treatment of bioprosthetic tissues to mitigate post implantation calcification
|
US8182841B2
(en)
|
2005-09-27 |
2012-05-22 |
Tissue Tech, Inc. |
Amniotic membrane preparations and purified compositions and anti-inflammation methods
|
US8187639B2
(en)
|
2005-09-27 |
2012-05-29 |
Tissue Tech, Inc. |
Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
|
MY149159A
(en)
|
2005-11-15 |
2013-07-31 |
Hoffmann La Roche |
Method for treating joint damage
|
WO2007103469A2
(en)
|
2006-03-06 |
2007-09-13 |
Aeres Biomedical Ltd. |
Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
|
CA2666485C
(en)
|
2006-10-27 |
2015-10-06 |
Edwards Lifesciences Corporation |
Biological tissue for surgical implantation
|
MX2009011996A
(es)
|
2007-05-07 |
2010-04-21 |
Medimmune Llc |
Anticuerpos anti-coestimulador inducible y su uso en el tratamiento de oncologia, transplante y enfermedad autoinmunologica.
|
US9101691B2
(en)
|
2007-06-11 |
2015-08-11 |
Edwards Lifesciences Corporation |
Methods for pre-stressing and capping bioprosthetic tissue
|
EP3025714B9
(en)
|
2007-09-14 |
2020-11-18 |
Biogen MA Inc. |
Compositions and methods for the treatment of progressive multifocal leukoencephalopathy (pml)
|
WO2009070642A1
(en)
*
|
2007-11-28 |
2009-06-04 |
Medimmune, Llc |
Protein formulation
|
US8357387B2
(en)
|
2007-12-21 |
2013-01-22 |
Edwards Lifesciences Corporation |
Capping bioprosthetic tissue to reduce calcification
|
US20090252725A1
(en)
*
|
2008-03-07 |
2009-10-08 |
Biogen Idec Ma Inc. |
Use of CD23 Antibodies to Treat Malignancies in Patients with Poor Prognosis
|
US9480549B2
(en)
|
2008-04-25 |
2016-11-01 |
Allosource |
Multi-layer tissue patches
|
US9358320B2
(en)
|
2008-04-25 |
2016-06-07 |
Allosource |
Multi-layer tissue patches
|
US20110129520A1
(en)
*
|
2008-04-25 |
2011-06-02 |
Simon Bogdansky |
Anti-Adhesion Barrier Wound Dressing Comprising Processed Amniotic Tissue and Method of Use
|
ES2438496T3
(es)
|
2008-08-01 |
2014-01-17 |
Ventirx Pharmaceuticals, Inc. |
Formulaciones de agonistas de receptores de tipo toll y su uso
|
AR073295A1
(es)
|
2008-09-16 |
2010-10-28 |
Genentech Inc |
Metodos para tratar la esclerosis multiple progresiva. articulo de fabricacion.
|
US20100105620A1
(en)
*
|
2008-10-10 |
2010-04-29 |
Anaphore, Inc. |
Polypeptides that bind Trail-R1 and Trail-R2
|
CA2743469C
(en)
|
2008-11-12 |
2019-01-15 |
Medimmune, Llc |
Antibody formulation
|
WO2010075249A2
(en)
|
2008-12-22 |
2010-07-01 |
Genentech, Inc. |
A method for treating rheumatoid arthritis with b-cell antagonists
|
JP5501439B2
(ja)
|
2009-04-02 |
2014-05-21 |
ロシュ グリクアート アクチェンゲゼルシャフト |
完全長抗体と単鎖Fabフラグメントとを含む多重特異的抗体
|
SG178177A1
(en)
|
2009-07-31 |
2012-03-29 |
Genentech Inc |
Inhibition of tumor metastasis using bv8- or g-csf-antagonists
|
MX2012003396A
(es)
|
2009-09-16 |
2012-04-10 |
Genentech Inc |
Complejos de proteina conteniendo helice super-enrollada y/o enlazador tether y usos de los mismos.
|
ES2530732T3
(es)
|
2009-09-17 |
2015-03-05 |
Hoffmann La Roche |
Procedimientos de diagnóstico para el cáncer de pulmón
|
JP2013507124A
(ja)
*
|
2009-10-09 |
2013-03-04 |
アナフォア インコーポレイテッド |
Il−23rを結合するポリペプチド
|
WO2011060015A1
(en)
|
2009-11-11 |
2011-05-19 |
Genentech, Inc. |
Methods and compositions for detecting target proteins
|
JP6184695B2
(ja)
|
2009-12-04 |
2017-08-23 |
ジェネンテック, インコーポレイテッド |
多重特異性抗体、抗体アナログ、組成物、及び方法
|
NZ602707A
(en)
|
2010-03-23 |
2014-05-30 |
Edwards Lifesciences Corp |
Methods of conditioning sheet bioprosthetic tissue
|
TW201138821A
(en)
|
2010-03-26 |
2011-11-16 |
Roche Glycart Ag |
Bispecific antibodies
|
KR20180053775A
(ko)
|
2010-04-23 |
2018-05-23 |
제넨테크, 인크. |
이종다량체 단백질의 생산
|
US8906601B2
(en)
|
2010-06-17 |
2014-12-09 |
Edwardss Lifesciences Corporation |
Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates
|
CN103068846B9
(zh)
|
2010-08-24 |
2016-09-28 |
弗·哈夫曼-拉罗切有限公司 |
包含二硫键稳定性Fv片段的双特异性抗体
|
WO2012045090A2
(en)
|
2010-10-01 |
2012-04-05 |
Ventirx Pharmaceuticals, Inc. |
Therapeutic use of a tlr agonist and combination therapy
|
CA2817216A1
(en)
|
2010-11-08 |
2012-05-18 |
F. Hoffmann-La Roche Ag |
Subcutaneously administered anti-il-6 receptor antibody
|
US9351829B2
(en)
|
2010-11-17 |
2016-05-31 |
Edwards Lifesciences Corporation |
Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability
|
SG191153A1
(en)
|
2010-12-23 |
2013-07-31 |
Hoffmann La Roche |
Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
|
US10689447B2
(en)
|
2011-02-04 |
2020-06-23 |
Genentech, Inc. |
Fc variants and methods for their production
|
BR112013019499B1
(pt)
|
2011-02-04 |
2023-01-10 |
Genentech, Inc. |
Proteína heteromultimérica variante ou anticorpo igg modificado, método para produzir uma proteína heteromultimérica variante ou anticorpo igg modificado, composição, método para preparar uma proteína heteromultimérica e proteína heteromultimérica variante
|
US20120203254A1
(en)
*
|
2011-02-07 |
2012-08-09 |
David Tak Wai Chiu |
Allogenic Vessel Nerve Conduit
|
KR102148063B1
(ko)
|
2011-03-31 |
2020-08-25 |
제넨테크, 인크. |
베타7 인테그린 길항제를 투여하는 방법
|
US9682044B2
(en)
|
2011-06-10 |
2017-06-20 |
Tissuetech, Inc. |
Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
|
US9358107B2
(en)
|
2011-06-30 |
2016-06-07 |
Edwards Lifesciences Corporation |
Systems, dies, and methods for processing pericardial tissue
|
JP6227527B2
(ja)
|
2011-07-04 |
2017-11-08 |
メゾブラスト,インコーポレーテッド |
リウマチ性疾患を予防または治療する方法
|
WO2013013708A1
(en)
|
2011-07-26 |
2013-01-31 |
Fundació Institut D'investigació Biomèdica De Bellvitge |
Treatment of acute rejection in renal transplant
|
JP2014525412A
(ja)
|
2011-08-17 |
2014-09-29 |
ジェネンテック, インコーポレイテッド |
難治性腫瘍における血管新生の阻害
|
US9585983B1
(en)
|
2011-10-12 |
2017-03-07 |
BioDlogics, LLC |
Wound covering and method of preparation
|
WO2013082511A1
(en)
|
2011-12-02 |
2013-06-06 |
Genentech, Inc. |
Methods for overcoming tumor resistance to vegf antagonists
|
WO2013101771A2
(en)
|
2011-12-30 |
2013-07-04 |
Genentech, Inc. |
Compositions and method for treating autoimmune diseases
|
MX2014009043A
(es)
|
2012-01-31 |
2014-10-14 |
Genentech Inc |
Anticuerpos anti-ige y sus metodos de uso.
|
JP6486686B2
(ja)
|
2012-02-10 |
2019-03-20 |
ジェネンテック, インコーポレイテッド |
単鎖抗体及び他のヘテロ多量体
|
US8835387B2
(en)
|
2012-02-16 |
2014-09-16 |
Atyr Pharma, Inc. |
Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
|
KR20150023889A
(ko)
|
2012-06-27 |
2015-03-05 |
에프. 호프만-라 로슈 아게 |
2 개 이상의 상이한 결합 단위를 함유하는 맞춤-제작된 고도로 선별적이고 다중-특이적인 표적화 단위의 선별 및 제조 방법 및 이의 용도
|
WO2014001325A1
(en)
|
2012-06-27 |
2014-01-03 |
F. Hoffmann-La Roche Ag |
Method for making antibody fc-region conjugates comprising at least one binding entity that specifically binds to a target and uses thereof
|
US10238771B2
(en)
|
2012-11-08 |
2019-03-26 |
Edwards Lifesciences Corporation |
Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system
|
US10905800B1
(en)
|
2013-01-29 |
2021-02-02 |
BioDlogics, LLC |
Ocular covering and method of use
|
KR102182488B1
(ko)
|
2013-02-25 |
2020-11-24 |
제넨테크, 인크. |
약물 내성 akt 돌연변이체의 검출 및 치료를 위한 방법 및 조성물
|
US9498327B1
(en)
|
2013-03-05 |
2016-11-22 |
Biodlogics Llc |
Repair of tympanic membrane using human birth tissue material
|
US9789138B1
(en)
|
2013-03-06 |
2017-10-17 |
BioDlogics, LLC |
Neural repair construct and method of use
|
US9770472B1
(en)
|
2013-03-08 |
2017-09-26 |
Brahm Holdings, Llc |
Organ jacket and methods of use
|
US9855301B1
(en)
|
2013-03-13 |
2018-01-02 |
Biodlogics Llc |
Human birth tissue laminate and methods of use
|
WO2014151517A1
(en)
|
2013-03-15 |
2014-09-25 |
Intermune, Inc. |
Methods of improving microvascular integrity
|
US9795638B1
(en)
|
2013-03-16 |
2017-10-24 |
BioDlogics, LLC |
Cardiothoracic construct and methods of use
|
SG11201507974RA
(en)
|
2013-03-27 |
2015-10-29 |
Genentech Inc |
Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists
|
US9615922B2
(en)
|
2013-09-30 |
2017-04-11 |
Edwards Lifesciences Corporation |
Method and apparatus for preparing a contoured biological tissue
|
US10959839B2
(en)
|
2013-10-08 |
2021-03-30 |
Edwards Lifesciences Corporation |
Method for directing cellular migration patterns on a biological tissue
|
KR102397324B1
(ko)
|
2014-03-27 |
2022-05-13 |
제넨테크, 인크. |
염증성 장 질환의 진단 및 치료 방법
|
KR20230164192A
(ko)
|
2014-05-06 |
2023-12-01 |
제넨테크, 인크. |
포유동물 세포를 사용한 이종다량체 단백질의 생산
|
AU2015314744A1
(en)
|
2014-09-12 |
2017-03-02 |
Genentech, Inc. |
Anti-CLL-1 antibodies and immunoconjugates
|
US10265438B1
(en)
|
2014-11-03 |
2019-04-23 |
BioDlogics, LLC |
Methods and compositions for the repair and replacement of connective tissue
|
EP3227332B1
(en)
|
2014-12-03 |
2019-11-06 |
F.Hoffmann-La Roche Ag |
Multispecific antibodies
|
CN107108739B
(zh)
|
2014-12-05 |
2022-01-04 |
豪夫迈·罗氏有限公司 |
抗CD79b抗体和使用方法
|
US20160243288A1
(en)
|
2015-02-23 |
2016-08-25 |
Tissuetech, Inc. |
Apparatuses and methods for treating ophthalmic diseases and disorders
|
CN113209289A
(zh)
|
2015-02-26 |
2021-08-06 |
豪夫迈·罗氏有限公司 |
治疗Crohn病的整联蛋白β7拮抗剂和方法
|
JP6996983B2
(ja)
|
2015-06-16 |
2022-02-21 |
ジェネンテック, インコーポレイテッド |
抗cll-1抗体及び使用方法
|
PE20221007A1
(es)
|
2015-06-24 |
2022-06-15 |
Hoffmann La Roche |
Anticuerpos anti-receptor de transferrina con afinidad disenada
|
US20170029520A1
(en)
|
2015-06-29 |
2017-02-02 |
Genentech, Inc. |
Compositions and methods for use in organ transplantation
|
CA2997801A1
(en)
|
2015-10-02 |
2017-04-06 |
F. Hoffmann-La Roche Ag |
Bispecific anti-human cd20/human transferrin receptor antibodies and methods of use
|
AR106189A1
(es)
|
2015-10-02 |
2017-12-20 |
Hoffmann La Roche |
ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
|
MA43345A
(fr)
|
2015-10-02 |
2018-08-08 |
Hoffmann La Roche |
Conjugués anticorps-médicaments de pyrrolobenzodiazépine et méthodes d'utilisation
|
IL293708A
(en)
|
2015-10-06 |
2022-08-01 |
Genentech Inc |
A method for treating multiple sclerosis
|
EP3397287A1
(en)
|
2015-12-30 |
2018-11-07 |
Genentech, Inc. |
Formulations with reduced degradation of polysorbate
|
TW201733600A
(zh)
|
2016-01-29 |
2017-10-01 |
帝聖工業公司 |
胎兒扶持組織物及使用方法
|
PL3458101T3
(pl)
|
2016-05-20 |
2021-05-31 |
F. Hoffmann-La Roche Ag |
Koniugaty PROTAC-przeciwciało i sposoby ich stosowania
|
US10687934B2
(en)
|
2016-07-05 |
2020-06-23 |
Carlos A. Alvarado |
Serous membrane for ocular surface disorders
|
KR20190091325A
(ko)
|
2016-12-07 |
2019-08-05 |
프로제너티, 인크. |
위장관 검출 방법, 디바이스 및 시스템
|
TW201834711A
(zh)
|
2016-12-14 |
2018-10-01 |
美商寶珍那提公司 |
以tnf抑制劑治療胃腸道疾病
|
EP3554344A1
(en)
|
2016-12-14 |
2019-10-23 |
Progenity, Inc. |
Treatment of a disease of the gastrointestinal tract with a tlr modulator
|
WO2018112237A1
(en)
|
2016-12-14 |
2018-06-21 |
Progenity Inc. |
Treatment of a disease of the gastrointestinal tract with an il-6r inhibitor
|
MX2019006823A
(es)
|
2016-12-14 |
2019-10-21 |
Progenity Inc |
Tratamiento de una enfermedad del tracto gastrointestinal con inhibidor de interleucina-12/interleucina-23 (il-12/il-23) liberado usando un dispositivo ingerible.
|
CA3045472A1
(en)
|
2016-12-14 |
2018-06-21 |
Progenity Inc. |
Treatment of a disease of the gastrointestinal tract with a smad7 inhibitor
|
US10980739B2
(en)
|
2016-12-14 |
2021-04-20 |
Progenity, Inc. |
Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
|
US11523772B2
(en)
|
2016-12-14 |
2022-12-13 |
Biora Therapeutics, Inc. |
Treatment of a disease of the gastrointestinal tract with an immunosuppressant
|
CA3045666A1
(en)
|
2016-12-14 |
2018-06-21 |
Progenity, Inc. |
Treatment of a disease of the gastrointestinal tract with a jak inhibitor and devices
|
EP3600414A1
(en)
|
2017-03-30 |
2020-02-05 |
Progenity Inc. |
Treatment of a disease of the gastrointestinal tract with il-10 or an il-10 agonist
|
AU2018244922A1
(en)
|
2017-03-30 |
2019-09-12 |
Biora Therapeutics, Inc. |
Treatment of a disease of the gastrointestinal tract with live biotherapeutics
|
WO2018183932A1
(en)
|
2017-03-30 |
2018-10-04 |
Progenity Inc. |
Treatment of a disease of the gastrointestinal tract with a il-13 inhibitor
|
US20200094031A1
(en)
|
2017-03-30 |
2020-03-26 |
Progenity, Inc. |
Treatment of a disease of the gastrointestinal tract with a chst15 inhibitor
|
WO2019040680A1
(en)
|
2017-08-23 |
2019-02-28 |
Krzar Life Sciences |
IMMUNOPROTEASOME INHIBITORS AND IMMUNOSUPPRESSANT AGENT IN THE TREATMENT OF AUTOIMMUNE DISORDERS
|
RU2698048C2
(ru)
|
2017-10-03 |
2019-08-21 |
Закрытое Акционерное Общество "Биокад" |
МОНОКЛОНАЛЬНОЕ АНТИТЕЛО К IL-5Rα
|
US20210031012A1
(en)
|
2018-01-26 |
2021-02-04 |
Progenity, Inc. |
Treatment of a disease of the gastrointestinal tract with a pde4 inhibitor
|
AU2019278927A1
(en)
|
2018-06-01 |
2020-12-24 |
Biora Therapeutics, Inc. |
Devices and systems for gastrointestinal microbiome detection and manipulation
|
US20230009902A1
(en)
|
2018-06-20 |
2023-01-12 |
Progenity, Inc. |
Treatment of a disease or condition in a tissue orginating from the endoderm
|
US11103619B2
(en)
|
2018-08-30 |
2021-08-31 |
Efstathios-Andreas AGATHOS |
Anticalcification treatment for impantable biological tissues using calcitonin
|
GB201814281D0
(en)
|
2018-09-03 |
2018-10-17 |
Femtogenix Ltd |
Cytotoxic agents
|
TW202037381A
(zh)
|
2018-10-24 |
2020-10-16 |
瑞士商赫孚孟拉羅股份公司 |
綴合化學降解誘導劑及使用方法
|
RU2724469C2
(ru)
|
2018-10-31 |
2020-06-23 |
Закрытое Акционерное Общество "Биокад" |
Моноклональное антитело, которое специфически связывается с cd20
|
CN113164258A
(zh)
|
2018-11-01 |
2021-07-23 |
爱德华兹生命科学公司 |
经导管再生肺动脉瓣
|
IL283268B1
(en)
|
2018-11-19 |
2024-05-01 |
Biora Therapeutics Inc |
Methods and devices for treating the disease with hyperpoietic substances
|
EP3884276A2
(en)
|
2018-11-23 |
2021-09-29 |
Katholieke Universiteit Leuven |
Predicting a treatment response in inflammatory bowel disease
|
GB201901197D0
(en)
|
2019-01-29 |
2019-03-20 |
Femtogenix Ltd |
G-A Crosslinking cytotoxic agents
|
EP3826664A4
(en)
|
2019-02-06 |
2022-10-26 |
Sangamo Therapeutics, Inc. |
METHOD FOR THE TREATMENT OF TYPE I MUCOPOLYSACCHARIDOSES
|
EP3946384A1
(en)
|
2019-04-02 |
2022-02-09 |
Sangamo Therapeutics, Inc. |
Methods for the treatment of beta-thalassemia
|
WO2021119482A1
(en)
|
2019-12-13 |
2021-06-17 |
Progenity, Inc. |
Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
|
GB2597532A
(en)
|
2020-07-28 |
2022-02-02 |
Femtogenix Ltd |
Cytotoxic compounds
|
TW202330613A
(zh)
|
2021-11-12 |
2023-08-01 |
美商建南德克公司 |
使用整聯蛋白β7拮抗劑治療克隆氏病之方法
|
WO2024127332A1
(en)
|
2022-12-14 |
2024-06-20 |
Pheon Therapeutics Ltd |
Cytotoxic compounds
|